Other

Pfizer lifts outlook as COVID-19 vaccine drives results

Pfizer again boosted its 2021 profit and revenue outlook on Tuesday, bolstered by the latest surge in COVID-19 vaccinations, including regulatory approvals for boosters and shots for younger children.

Medications

Suvorexant may improve insomnia with Alzheimer disease

(HealthDay)—Suvorexant improves total sleep time (TST) in patients with probable Alzheimer disease (AD) dementia and insomnia, according to a study published online Jan. 15 in Alzheimer's & Dementia.

Other

Swiss pharma Novartis ups full-year sales outlook (Update)

Swiss pharmaceutical giant Novartis AG raised its full-year sales outlook because of delays in generic competition to its blockbuster blood pressure drug Diovan, even though it said negative currency trends contributed to ...

page 1 from 3